Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Feb-24 7:54 PM View:  | Hastings David C Chief Financial Officer | Arbutus Biopharma Corp (ABUS) | 02-Feb-24 | Sale (Planned) | 9,593 | $2.31 | $22,183.80 | (5%) 191.5K to 181.91K | |
| 05-Feb-24 7:54 PM View: | McElhaugh Michael J. Interim President & CEO Director | Arbutus Biopharma Corp (ABUS) | 02-Feb-24 | Sale (Planned) | 10,164 | $2.31 | $23,504.20 | (< 1%) 1.51M to 1.5M | |
| 05-Feb-24 7:55 PM View: | Sims Karen Chief Medical Officer | Arbutus Biopharma Corp (ABUS) | 02-Feb-24 | Sale (Planned) | 4,358 | $2.31 | $10,077.90 | (3%) 129.9K to 125.54K | |
| 05-Feb-24 7:54 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 02-Feb-24 | Sale (Planned) | 9,982 | $2.31 | $23,083.40 | (< 1%) 1.66M to 1.65M | |
| 05-Feb-24 7:54 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 01-Feb-24 | Grant | 109,500 | -- | -- | 7% 1.55M to 1.66M | |
| 05-Feb-24 7:55 PM View: | Naftzger J. Christopher General Counsel and CCO | Arbutus Biopharma Corp (ABUS) | 01-Feb-24 | Grant | 95,100 | -- | -- | 100% 0 to 95.1K | |
| 05-Feb-24 7:54 PM View: | Hastings David C Chief Financial Officer | Arbutus Biopharma Corp (ABUS) | 01-Feb-24 | Grant | 112,500 | -- | -- | 142% 79.0K to 191.5K | |
| 05-Feb-24 7:54 PM View: | McElhaugh Michael J. Interim President & CEO Director | Arbutus Biopharma Corp (ABUS) | 01-Feb-24 | Grant | 123,800 | -- | -- | 9% 1.39M to 1.51M | |
| 05-Feb-24 7:55 PM View: | Sims Karen Chief Medical Officer | Arbutus Biopharma Corp (ABUS) | 01-Feb-24 | Grant | 101,000 | -- | -- | 349% 28.9K to 129.9K | |
| 03-Feb-23 4:10 PM View: | Howard Elizabeth EVP, GC, Compliance | Arbutus Biopharma Corp (ABUS) | 01-Feb-23 | Grant | 69,700 | -- | -- | 427% 16.32K to 86.02K | |
| 03-Feb-23 4:11 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 01-Feb-23 | Grant | 82,200 | -- | -- | 6% 1.47M to 1.55M | |
| 03-Feb-23 4:10 PM View: | Collier William H. President and CEO Director | Arbutus Biopharma Corp (ABUS) | 01-Feb-23 | Grant | 216,500 | -- | -- | 100% 0 to 216.5K | |
| 03-Feb-23 4:12 PM View: | McElhaugh Michael J. Chief Business Officer | Arbutus Biopharma Corp (ABUS) | 01-Feb-23 | Grant | 83,700 | -- | -- | 6% 1.31M to 1.39M | |
| 03-Feb-23 4:11 PM View: | Hastings David C Chief Financial Officer | Arbutus Biopharma Corp (ABUS) | 01-Feb-23 | Grant | 79,000 | -- | -- | 100% 0 to 79.0K | |
| 03-Dec-21 4:02 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 01-Dec-21 | Market Sale (Planned) | 200,000 | $5.09 | $1,018,000.00 | (12%) 1.67M to 1.47M | 15% |
| 20-Oct-21 5:14 PM View: | Roivant Sciences Ltd. 10% Owner | Arbutus Biopharma Corp (ABUS) | 18-Oct-21 | Conversion | 22,833,900 | -- | -- | 143% 16.01M to 38.85M | |
| 10-Feb-21 5:06 PM View: | McElhaugh Michael J. Chief Business Officer | Arbutus Biopharma Corp (ABUS) | 09-Feb-21 | Market Sale (Planned) | 20,000 | $5.00 | $100,000.00 | (2%) 1.33M to 1.31M | 11% |
| 16-Dec-20 4:33 PM View: | McElhaugh Michael J. Chief Business Officer | Arbutus Biopharma Corp (ABUS) | 14-Dec-20 | Market Sale (Planned) | 40,000 | $5.00 | $200,032.00 | (3%) 1.37M to 1.33M | |
| 27-Jul-20 5:27 PM View: | McElhaugh Michael J. Chief Business Officer | Arbutus Biopharma Corp (ABUS) | 23-Jul-20 | Market Sale (Planned) | 20,000 | $5.01 | $100,200.00 | (1%) 1.39M to 1.37M | |
| 30-Nov-18 4:55 PM View: | Murray Mark J. Director | Arbutus Biopharma Corp (ABUS) | 28-Nov-18 | Option Exercise | 25,000 | $1.35 | $33,750.00 | 8% 316.4K to 341.4K | |
| 14-Aug-18 6:23 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 13-Aug-18 | Market Sale | 4,250 | $9.51 | $40,435.80 | (< 1%) 1.67M to 1.67M | |
| 13-Jul-18 1:36 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 11-Jul-18 | Market Sale (Planned) | 10,000 | $10.00 | $100,000.00 | (< 1%) 1.68M to 1.67M | |
| 10-Jul-18 1:11 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 09-Jul-18 | Market Sale (Planned) | 10,000 | $8.91 | $89,060.00 | (< 1%) 1.69M to 1.68M | |
| 10-Jul-18 1:11 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 06-Jul-18 | Market Sale (Planned) | 10,000 | $8.45 | $84,500.00 | (< 1%) 1.7M to 1.69M | |
| 06-Jul-18 4:05 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 05-Jul-18 | Market Sale (Planned) | 10,000 | $8.40 | $84,000.00 | (< 1%) 1.71M to 1.7M | |
| 06-Jul-18 4:05 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 03-Jul-18 | Market Sale (Planned) | 10,000 | $8.00 | $80,000.00 | (< 1%) 1.72M to 1.71M | |
| 17-Apr-18 8:22 PM View: | Murray Mark J. President & CEO Director | Arbutus Biopharma Corp (ABUS) | 17-Apr-18 | Option Exercise | 27,007 | $0.35 | $9,560.48 | 9% 289.39K to 316.4K | |
| 05-Oct-17 6:34 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 03-Oct-17 | Market Sale (Planned) | 10,000 | $8.00 | $80,000.00 | (< 1%) 1.73M to 1.72M | 29% |
| 17-Aug-17 7:41 PM View: | Sofia Michael J. Chief Scientific Officer | Arbutus Biopharma Corp (ABUS) | 15-Aug-17 | Market Sale | 30,000 | $3.70 | $111,000.00 | (2%) 1.76M to 1.73M | (53%) |
| 18-Aug-16 6:11 PM View: | Abrams Michael J. Managing Director | Arbutus Biopharma Corp (ABUS) | 16-Aug-16 | Option Exercise | 14,178 | $0.35 | $4,898.50 | 51% 27.92K to 42.1K | |
| 20-Jun-16 8:33 PM View: | Murray Mark J. President & CEO Director | Arbutus Biopharma Corp (ABUS) | 16-Jun-16 | Exercise (in-the money or at-the-money) | 5,000 | $2.57 | $12,844.00 | 2% 284.39K to 289.39K | |
| 15-Sep-15 4:20 PM View: | Murray Mark J. President & CEO Director | Arbutus Biopharma Corp (ABUS) | 11-Sep-15 | Option Exercise | 219,428 | $0.44 | $97,513.80 | 338% 64.96K to 284.39K | |
| 15-Sep-15 4:18 PM View: | Abrams Michael J. Managing Director | Arbutus Biopharma Corp (ABUS) | 11-Sep-15 | Option Exercise | 17,044 | $0.44 | $7,574.35 | 157% 10.88K to 27.92K | |
| 26-Aug-15 1:29 PM View: | Henriques Richard C Jr Director | Arbutus Biopharma Corp (ABUS) | 24-Aug-15 | Market Purchase | 1,000 | $6.95 | $6,950.00 | 100% 0 to 1.0K | (17%) |
